Medicine
Triamcinolone acetonide 0.025% ointment
Triamcinolone acetonide 0.025% ointment is a generic prescription medicine for topical use, made by 8 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20 to 25°C (68 to 77°F).
Key facts
- Active ingredient (INN)
- Triamcinolone acetonide
- Brand
- Sold under the generic name
- Strength
- 0.025%
- Dosage form
- Ointment
- Route
- Topical
- Packs
- 1 tube, 454 g, 80 g and 15 more
- Manufacturers
- Macleods PharmaceuticalsIndiaBryant Ranch PrepackNorthStar RxLLCPadagis Israel PharmaceuticalsA-S Medication SolutionsCosette PharmaceuticalsAsclemedE. Fougera
- Origin register
- US FDA, United States
- Storage
- Store at 20 to 25°C (68 to 77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.32Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 14 February 1978
- Identifiers
- RxCUI 1085633, 1085636, 1085640DailyMed set ID b20c22b2-9a74-4b71-9015-40838fd2d193, 5397395a-2d13-9311-7cb2-c316339d4acc, 838ba2fa-5133-4975-bd99-791891a144c5 +7NDC 76420-360, 0713-0229, 45802-054 +7Application ANDA085691, ANDA089795, ANDA087385 +1
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 tube in 1 carton / 15 g in 1 tube | 33342-331-15 | Macleods PharmaceuticalsIndia | 23 November 2018 |
| 454 g in 1 jar | 33342-331-54 | Macleods PharmaceuticalsIndia | 23 November 2018 |
| 1 tube in 1 carton / 80 g in 1 tube | 33342-331-80 | Macleods PharmaceuticalsIndia | 23 November 2018 |
| 1 tube in 1 carton / 15 g in 1 tube | 0713-0229-15 | Cosette Pharmaceuticals | 10 September 2015 |
| 1 tube in 1 carton / 80 g in 1 tube | 0713-0229-80 | Cosette Pharmaceuticals | 10 September 2015 |
| 80 g in 1 tube | 0168-0005-80 | E. Fougera | 14 February 1978 |
| 454 g in 1 jar | 45802-054-05 | Padagis Israel Pharmaceuticals | 5 July 2007 |
| 1 tube in 1 carton / 15 g in 1 tube | 45802-054-35 | Padagis Israel Pharmaceuticals | 12 May 2006 |
| 1 tube in 1 carton / 80 g in 1 tube | 45802-054-36 | Padagis Israel Pharmaceuticals | 5 September 2007 |
| 1 tube in 1 carton / 15 g in 1 tube | 50090-0362-0 | A-S Medication Solutions | 29 June 2016 |
| 1 tube in 1 carton / 15 g in 1 tube | 50090-3802-0 | A-S Medication Solutions | 9 November 2018 |
| 80 g in 1 tube | 63629-8841-1 | Bryant Ranch Prepack | 10 September 2021 |
| 1 tube in 1 carton / 15 g in 1 tube | 72162-2335-2 | Bryant Ranch Prepack | 18 June 2024 |
| 1 tube in 1 carton / 80 g in 1 tube | 72162-2335-4 | Bryant Ranch Prepack | 18 June 2024 |
| 80 g in 1 tube | 76420-360-80 | Asclemed | 23 May 2025 |
| 1 tube in 1 carton / 15 g in 1 tube | 16714-267-01 | NorthStar RxLLC | 21 April 2022 |
| 1 tube in 1 carton / 80 g in 1 tube | 16714-267-02 | NorthStar RxLLC | 21 April 2022 |
| 454 g in 1 jar | 16714-267-03 | NorthStar RxLLC | 21 April 2022 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 23 October 1958 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Triamcinolone acetonide
Clinical summary
Triamcinolone acetonide is a corticosteroid indicated as adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in acute gouty arthritis, acute and subacute bursitis, acute nonspecific tenosynovitis, epicondylitis, rheumatoid arthritis. MedsAcross supplies Triamcinolone acetonide for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Triamcinolone acetonideFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- KENALOG-10 prescribing information (ER Squibb & Sons) · U.S. National Library of Medicine, DailyMed
Need Triamcinolone acetonide 0.025% ointment for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.